Ardelyx (ARDX) Gross Margin (2015 - 2026)

Ardelyx (ARDX) posted Gross Margin of 94.91% for Q1 2026, up 3.91% on a QoQ basis from 91.34% in Q4 2025, and up 1151.0% year-over-year from 7.59% in Q1 2025.

Ardelyx (ARDX) Gross Margin (2015 - 2026) Analysis & Trends

Ardelyx's Gross Margin history runs 10 years deep, the most recent figure standing at 94.91% for Q1 2026.

  • Quarterly Gross Margin rose 1151.0% year-over-year to 94.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 90.01% (up 542.0% YoY) and the FY2025 annual result came in at 90.29%, up 545.0% from the prior year.
  • Gross Margin was 94.91% for Q1 2026 at Ardelyx, up from 91.34% in the prior quarter.
  • Across five years, Gross Margin topped out at 94.91% in Q1 2026 and bottomed at 17.12% in Q3 2025.
  • A 5-year average of 80.98% and a median of 85.32% in 2022 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2025 — Gross Margin tumbled 10111 bps — and 2026, when it surged 1151 bps.
  • Ardelyx's Gross Margin stood at 92.84% in 2022, then decreased by 8 bps to 85.23% in 2023, then declined by 1 bps to 84.27% in 2024, then gained by 8 bps to 91.34% in 2025, then advanced by 4 bps to 94.91% in 2026.
  • Business Quant data shows ARDX's Gross Margin at 94.91% in Q1 2026, 91.34% in Q4 2025, and 17.12% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 94.91%

Historic Data

Download Data
DateValue
Mar 31, 2026 94.91%
Dec 31, 2025 91.34%
Sep 30, 2025 -17.12%
Jun 30, 2025 87.30%
Mar 31, 2025 83.40%
Dec 31, 2024 84.27%
Sep 30, 2024 83.99%
Jun 30, 2024 87.11%
Mar 31, 2024 84.51%
Dec 31, 2023 85.23%
Sep 30, 2023 86.36%
Jun 30, 2023 84.38%
Mar 31, 2023 86.48%
Dec 31, 2022 92.84%
Sep 30, 2022 85.32%
Jun 30, 2022 94.54%
Mar 31, 2022 81.84%
Dec 31, 2021 100.00%
Sep 30, 2021 100.00%
Jun 30, 2021 100.00%